Inventor · disambiguated record
Erik Alphie Lachapelle
Also filed as: LACHAPELLE ERIK ALPHIE
24 granted patents·5 pending applications·116 citations·filing 2013–2023
95Inventor score
Files withPFIZER29
Top patents by PatentIndex Score
29 records- 0194US9315520B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2015·Granted Apr 19, 2016·15 cites·26 claims
- 0293US9428523B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2016·Granted Aug 30, 2016·12 cites·37 claims
- 0393US9192612B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2015·Granted Nov 24, 2015·13 cites·17 claims
- 0493US9045499B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Jun 2, 2015·17 cites·7 claims
- 0593US8865706B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Oct 21, 2014·19 cites·9 claims
- 0691US9605007B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2016·Granted Mar 28, 2017·8 cites·6 claims
- 0789US11472805B2Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2016·Granted Oct 18, 2022·4 cites·24 claims
- 0889US10604519B25,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2017·Granted Mar 31, 2020·3 cites·24 claims
- 0988US11339159B2Toll-like receptor agonistsPFIZER·Filed 2020·Granted May 24, 2022·2 cites·30 claims
- 1088US9598421B2Imidazopyridazine compoundsPFIZER·Filed 2015·Granted Mar 21, 2017·6 cites·24 claims
- 1185US10028962B22-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2017·Granted Jul 24, 2018·3 cites·40 claims
- 1284US9403846B2Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2013·Granted Aug 2, 2016·7 cites·19 claims
- 1383US10738063B26,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compoundsPFIZER·Filed 2019·Granted Aug 11, 2020·3 cites·16 claims
- 1483US2024190869A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2023·Application pending·0 cites
- 1582US9744173B22-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2017·Granted Aug 29, 2017·2 cites·24 claims
- 1681US2023192690A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2023·Application pending·0 cites
- 1777US11905284B25,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2021·Granted Feb 20, 2024·0 cites·18 claims
- 1876US12049465B2Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2022·Granted Jul 30, 2024·0 cites·10 claims
- 1975US12398119B2Piperazine azaspiro derivativesPFIZER·Filed 2022·Granted Aug 26, 2025·0 cites·3 claims
- 2075US10323042B26,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compoundsPFIZER·Filed 2017·Granted Jun 18, 2019·1 cites·18 claims
- 2174US10077269B2Imidazopyridazine compoundsPFIZER·Filed 2017·Granted Sep 18, 2018·1 cites·7 claims
- 2273US2023146535A1Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2022·Application pending·0 cites
- 2370US11976064B2Toll-like receptor agonistsPFIZER·Filed 2022·Granted May 7, 2024·0 cites·14 claims
- 2469US10669279B2Imidazopyridazine compoundsPFIZER·Filed 2019·Granted Jun 2, 2020·0 cites·22 claims
- 2568US2020207762A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2020·Application pending·0 cites
- 2660US2018346475A1Imidazopyridazine CompoundsPFIZER·Filed 2018·Application pending·0 cites
- 2752US11524954B2Piperazine azaspiro derivativesPFIZER·Filed 2019·Granted Dec 13, 2022·0 cites·30 claims
- 2843US11198692B2Dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2018·Granted Dec 14, 2021·0 cites·21 claims
- 2935US10131669B2Pyrazolopyrimidine compoundsPFIZER·Filed 2015·Granted Nov 20, 2018·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Erik Alphie Lachapelle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →